Recent studies have reported that elevation of TNF-α and IL-2 in tissues by transfecting oncolytic adenovirus loaded with TNF-α and IL-2 sequence into T cells modulates host tumor immune status and orchestrates TAMs toward the M1 type (Watanabe et al., 2018). The gene discussed is TNF; the disease is neoplasm.